Compass Therapeutics (CMPX) Income Statement: Revenue & Earnings

Compass Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Compass Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.85	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.85	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	42.34	38.12	30.00	20.34	14.90
Selling, General & Administrative	15.13	12.24	11.66	10.93	12.91
Operating Expenses	57.48	50.36	41.66	31.26	27.81
Operating Income	-56.63	-50.36	-41.66	-31.26	-27.81
Other Income/Expense
Interest Income	7.30	7.90	2.36	0.03	0.09
Interest Expense	0.00	0.00	0.00	-0.37	-0.91
Other Income/Expense	-0.05	-0.03	0.07	0.30	1.66
Income
Income Before Tax	-49.38	-42.49	-39.23	-82.18	-29.47
Income Tax Expense	0.00	0.00	0.00	0.00	0.03
Net Income	-49.38	-42.49	-39.23	-82.18	-29.50
Net Income - Continuous Operations	-49.38	-42.49	-39.23	-82.18	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-54.87	-48.47	-40.87	-30.70	-26.16
EBIT	-56.63	-50.36	-41.66	-31.26	-28.56
Depreciation & Amortization	1.75	1.89	0.78	0.57	2.40
Earnings Per Share
Basic EPS	-	-	-	-1.00	-1.00
Diluted EPS	-	-	-	-1.00	-1.00
Basic Shares Outstanding	137.15	127.03	105.19	62.87	30.78
Diluted Shares Outstanding	137.15	127.03	105.19	62.87	30.78